UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Sie befinden Sich nicht im Netzwerk der Universität Paderborn. Der Zugriff auf elektronische Ressourcen ist gegebenenfalls nur via VPN oder Shibboleth (DFN-AAI) möglich. mehr Informationen...

Cancer of the ovary, fallopian tube, and peritoneum: 2021 update

International journal of gynecology and obstetrics, 2021-10, Vol.155 (S1), p.61-85

2021

Link zum Volltext

Verfügbarkeit prüfen

Cancer of the ovary, fallopian tube, and peritoneum

International journal of gynecology and obstetrics, 2018-10, Vol.143 (S2), p.59-78

2018

Link zum Volltext

Verfügbarkeit prüfen

Revised FIGO staging for carcinoma of the cervix uteri

International journal of gynecology and obstetrics, 2019-04, Vol.145 (1), p.129-135

2019

Link zum Volltext

Verfügbarkeit prüfen

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

The lancet oncology, 2019-05, Vol.20 (5), p.636-648

2019

Link zum Volltext

Verfügbarkeit prüfen

Cancer of the ovary, fallopian tube, and peritoneum

International journal of gynecology and obstetrics, 2015-10, Vol.131 (S2), p.S111-S122

2015

Link zum Volltext

Verfügbarkeit prüfen

Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study

Obstetrics and gynecology (New York. 1953), 2009-05, Vol.113 (5), p.1027-1037

2009

Link zum Volltext

Verfügbarkeit prüfen

Cancer of the ovary, fallopian tube, and peritoneum

International journal of gynaecology and obstetrics, 2012-10, Vol.119 (S2), p.S118-S129

2012

Link zum Volltext

Verfügbarkeit prüfen

Rethinking ovarian cancer: recommendations for improving outcomes

Nature reviews. Cancer, 2011-10, Vol.11 (10), p.719

2011

Link zum Volltext

Verfügbarkeit prüfen

FIGO staging for carcinoma of the vulva: 2021 revision

International journal of gynecology and obstetrics, 2021-10, Vol.155 (1), p.43-47

2021

Link zum Volltext

Verfügbarkeit prüfen

The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis

Gynecological Surgery, 2015, Vol.12 (3), p.165-177

2015

Link zum Volltext

Verfügbarkeit prüfen

Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry

Cell reports (Cambridge), 2018-02, Vol.22 (7), p.1875-1888

2018

Link zum Volltext

Verfügbarkeit prüfen

FIGO staging of endometrial cancer: 2023

Journal of Gynecologic Oncology, 2023, 34(5), , pp.1-18

2023

Link zum Volltext

Verfügbarkeit prüfen

Development of Therapeutic Vaccines for Ovarian Cancer

Vaccines (Basel), 2020-11, Vol.8 (4), p.657

2020

Link zum Volltext

Verfügbarkeit prüfen

Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix

Journal of clinical oncology, 2000-04, Vol.18 (8), p.1606-1613

2000

Link zum Volltext

Verfügbarkeit prüfen

Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol

PloS one, 2023-01, Vol.18 (1), p.e0278077-e0278077

2023

Link zum Volltext

Verfügbarkeit prüfen

Ovarian conservation at the time of hysterectomy for benign disease

Obstetrics and gynecology (New York. 1953), 2005-08, Vol.106 (2), p.219-226

2005

Link zum Volltext

Verfügbarkeit prüfen

Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA

Gynecologic oncology, 2005-10, Vol.99 (1), p.153-159

2005

Link zum Volltext

Verfügbarkeit prüfen

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

Annals of surgical oncology, 2012-02, Vol.19 (2), p.597-604

2012

Link zum Volltext

Verfügbarkeit prüfen

Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update

JCO global oncology, 2022-03, Vol.8 (8), p.e2200027

2022

Link zum Volltext

Verfügbarkeit prüfen

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

Nature reviews. Cancer, 2015-11, Vol.15 (11), p.668

2015

Link zum Volltext

Verfügbarkeit prüfen

Personalizing CA125 levels for ovarian cancer screening

Cancer prevention research (Philadelphia, Pa.), 2011-09, Vol.4 (9), p.1356-1359

2011

Link zum Volltext

Verfügbarkeit prüfen

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

British journal of cancer, 2011-09, Vol.105 (7), p.890-896

2011

Link zum Volltext

Verfügbarkeit prüfen

Ovarian cancer in younger vs older women : a population-based analysis

British journal of cancer, 2006-11, Vol.95 (10), p.1314-1320

2006

Link zum Volltext

Verfügbarkeit prüfen

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths

American journal of obstetrics and gynecology, 2008-02, Vol.198 (2), p.218.e1-218.e6

2008

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 1.526

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(1.233)
Mit Volltextzugriff
(1.329)

Publikationsform

3 weitere anzeigen...

Weniger anzeigen...

Sprache

6 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(10)
... seit 90 Tagen
(59)

Menü

Weitere Dienste

Einstellungen

Cancer of the ovary, fallopian tube, and peritoneum: 2021 update

Cancer of the ovary, fallopian tube, and peritoneum

Revised FIGO staging for carcinoma of the cervix uteri

Niraparib monotherapy for late-line treatment of ovarian cancer (QUADRA): a multicentre, open-label, single-arm, phase 2 trial

Cancer of the ovary, fallopian tube, and peritoneum

Ovarian Conservation at the Time of Hysterectomy and Long-Term Health Outcomes in the Nurses’ Health Study

Cancer of the ovary, fallopian tube, and peritoneum

Abagovomab As Maintenance Therapy in Patients With Epithelial Ovarian Cancer: A Phase III Trial of the AGO OVAR, COGI, GINECO, and GEICO—The MIMOSA Study

Rethinking ovarian cancer: recommendations for improving outcomes

FIGO staging for carcinoma of the vulva: 2021 revision

The prevalence of occult leiomyosarcoma at surgery for presumed uterine fibroids: a meta-analysis

Commonly Occurring Cell Subsets in High-Grade Serous Ovarian Tumors Identified by Single-Cell Mass Cytometry

FIGO staging of endometrial cancer: 2023

Development of Therapeutic Vaccines for Ovarian Cancer

Concurrent Chemotherapy and Pelvic Radiation Therapy Compared With Pelvic Radiation Therapy Alone as Adjuvant Therapy After Radical Surgery in High-Risk Early-Stage Cancer of the Cervix

Comparative Assessment of p16/Ki-67 Dual Staining Technology for cervical cancer screening in women living with HIV (COMPASS-DUST)-Study protocol

Ovarian conservation at the time of hysterectomy for benign disease

Pelvic exenteration for recurrent gynecologic malignancy: Survival and morbidity analysis of the 45-year experience at UCLA

A Risk Model for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer: An Evidence-Based Proposal for Patient Selection

Management and Care of Patients With Invasive Cervical Cancer: ASCO Resource-Stratified Guideline Rapid Recommendation Update

Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer

Personalizing CA125 levels for ovarian cancer screening

Predictors of survival in patients with recurrent ovarian cancer undergoing secondary cytoreductive surgery based on the pooled analysis of an international collaborative cohort

Ovarian cancer in younger vs older women : a population-based analysis

Trends in demographic and clinical characteristics in women diagnosed with corpus cancer and their potential impact on the increasing number of deaths

Suchergebnisse filtern